Evidence map›Paper›PMID 30667167›Full record

ArticleAging cell2019

The TrkB-T1 receptor mediates BDNF-induced migration of aged cardiac microvascular endothelial cells by recruiting Willin.

Zhefeng Wang, Yilin Chen, Xuwei Chen, Xin Zheng, Ganlin Xu, Ziqiang Yuan, Hui Zhao, Wensheng Chen, Lilin Li, Nianjue Zheng and 4 more

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Protective effects of exerkine on cardiovascular system.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Zhefeng WangKey Laboratory of Regenerative Medicine, Ministry of Education, Jinan University, Guangzhou, China.ORCID 0000-0002-8274-8447
Yilin ChenKey Laboratory of Regenerative Medicine, Ministry of Education, Jinan University, Guangzhou, China.
Xuwei ChenKey Laboratory of Regenerative Medicine, Ministry of Education, Jinan University, Guangzhou, China.
Xin ZhengKey Laboratory of Regenerative Medicine, Ministry of Education, Jinan University, Guangzhou, China.
Ganlin XuKey Laboratory of Regenerative Medicine, Ministry of Education, Jinan University, Guangzhou, China.
Ziqiang YuanDepartment of Medical Oncology, Cancer Institute of New Jersey, Robert Wood Johnson of Medical School, New Brunswick, New Jersey.
Hui ZhaoStem Cell and Regeneration TRP, School of Biomedical Sciences, Chinese University of Hong Kong, Hong Kong, Hong Kong.
Wensheng ChenKey Laboratory of Regenerative Medicine, Ministry of Education, Jinan University, Guangzhou, China.
Lilin LiKey Laboratory of Regenerative Medicine, Ministry of Education, Jinan University, Guangzhou, China.
Nianjue ZhengKey Laboratory of Regenerative Medicine, Ministry of Education, Jinan University, Guangzhou, China.
Xiaotao ShenKey Laboratory of Regenerative Medicine, Ministry of Education, Jinan University, Guangzhou, China.
Yanmei LiKey Laboratory of Regenerative Medicine, Ministry of Education, Jinan University, Guangzhou, China.
Xufeng QiKey Laboratory of Regenerative Medicine, Ministry of Education, Jinan University, Guangzhou, China.
Dongqing CaiKey Laboratory of Regenerative Medicine, Ministry of Education, Jinan University, Guangzhou, China.
Jinan University · CNChinese University of Hong Kong · HKJohnson University · US

Funding

Guangdong Natural Science Funds for Distinguished Young Scholar 2014A030306011Major Research plan of the National Natural Science Foundation of China-Key program 91649203National Key R&D Program of China 2016YFE0204700National Key R&D Program of China 2017YFA0103302National Natural Science Foundation of China 81170324National Natural Science Foundation of China 81470433National Natural Science Foundation of China 81670236Research grant of the Department of Education of Guangdong 2012gjhz0003Science and Technology Planning Project of Guangdong Province 2015B020211010
6 · The paper itself

Abstract

The mechanism of age-related decline in the angiogenic potential of the myocardium is not yet fully understood. Our previous report revealed that the aging of cardiac microvascular endothelial cells (CMECs) led to changes in their expression of receptor Trk isoforms: among the three isoforms (TrkB-FL, TrkB-T1 and TrkB-T2), only the truncated TrkB-T1 isoform continued to be expressed in aged CMECs, which led to decreased migration of CMECs in aging hearts. Thus far, how BDNF induces signalling through the truncated TrkB-T1 isoform in aged CMECs remains unclear. Here, we first demonstrated that aged CMECs utilize BDNF-TrkB-T1 signalling to recruit Willin as a downstream effector to further activate the Hippo pathway, which then promotes migration. These findings suggest that the aging process shifts the phenotype of aged CMECs that express TrkB-T1 receptors by transducing BDNF signals via the BDNF-TrkB-T1-Willin-Hippo pathway and that this change might be an important mechanism and therapeutic target of the dysfunctional cardiac angiogenesis observed in aged hearts.

Indexed as

Cellular SenescenceAnimalsBrain-Derived Neurotrophic FactorCell MovementCells, CulturedEndothelial CellsHEK293 CellsHumansIntracellular Signaling Peptides and ProteinsMyocytes, CardiacNeovascularization, PhysiologicRatsReceptor, trkBSignal TransductionBdnf protein, mouseBrain-Derived Neurotrophic FactorFrmd6 protein, mouseIntracellular Signaling Peptides and ProteinsReceptor, trkBBDNF-TrkBcardiac microvascular endothelial cell agingHippo pathwaymigrationWillin/FRMD6

Identifiers

PMID30667167
PMCPMC6413668
OpenAlexW2913780003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.